The Days and Nights of David Perry
Executive Summary
Chemdex is leading the revolution in B2B e-commerce in health care with a business model that argues that what hospitals want isn't a web site from which to order supplies, but an end-to-end solution that ties to their ERP systems. Having built a $4 billion company virtually overnight, Chemdex CEO David Perry isn't sleeping much these days. And he's nowhere close to being done yet.
You may also be interested in...
Lessons Learned: David Perry, from Chemdex to Anacor
Six years ago, David Perry was one of the rock stars of the Web, the founding CEO of Chemdex-Ventro. He stuck with it as the company unraveled, shutting down most of the businesses he'd built, and merging the remainder into what is now an OTC-traded software company. Now he's applying the lessons he learned to his current company, Anacor Pharmaceuticals, a start-up which has discovered a small handful of now clinical-stage compounds.
Lessons Learned: David Perry, from Chemdex to Anacor
Six years ago, David Perry was one of the rock stars of the Web, the founding CEO of Chemdex-Ventro. He stuck with it as the company unraveled, shutting down most of the businesses he'd built, and merging the remainder into what is now an OTC-traded software company. Now he's applying the lessons he learned to his current company, Anacor Pharmaceuticals, a start-up which has discovered a small handful of now clinical-stage compounds.
BioSample Inc.
In the course of validating disease targets or developing drugs, researchers need tissue samples from patients with specific types of diseases as well as from healthy patients.BioSample Inc., has an internet-enabled biological material procurement solution to the pharmaceutical/biotech community.